Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline ProgressUnusual Whales·13 hours agoCNTX+1145.00%
Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business UpdateUnusual Whales·21 hours agoKYMR+104.00%
Kindred Companion Sciences Unveils First Dogs Genetically Edited to Remove the Major Dog AllergenUnusual Whales·22 hours ago
Promising Medical Stocks To Research - August 3rdMarket Beat·2 days ago, 12:02 PMDXCM-492.00%BSX-275.00%
Design Therapeutics Provides RESTORE-FA Clinical Development Update and Reports Second Quarter 2026 Financial ResultsUnusual Whales·2 days ago, 07:03 AMDSGN+280.00%
Restart Life Sciences Strengthens Operational Infrastructure to Scale "Better-for-You" Portfolio | NMLSF Stock NewsStockTitan·May 8 at 12:05 AMATNF0.00%ATNFW0.00%
Restart Life Announces Collaboration with University of Manitoba's Centre for Food Technology and Research | NMLSF Stock NewsStockTitan·Mar 2 at 09:00 PMATNF0.00%ATNFW0.00%
Restart Life Sciences Becomes Revenue Producer With Holy Crap Foods AcquisitionTip Ranks·Feb 27 at 08:21 AMIBB+87.00%XHE-227.00%
180 LIFE SCIENCES CORP C/WTS 07/11/2025(TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -0.3Earnings Watch·Jul 23, 2025 at 03:17 PMATNFW0.00%ETHZW0.00%
180 LIFE SCIENCES CORP C/WTS 07/11/2025(TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -0.67Earnings Watch·May 15, 2025 at 03:27 PMATNFW0.00%ETHZW0.00%
